期刊文献+

Overview of host-directed antiviral targets for future research and drug development

原文传递
导出
摘要 Viruses constitute a significant group of pathogens that have caused numerous fatalities and substantial economic losses in recent years,particularly with the emergence of coronaviruses.While the impact of SARS-CoV-2 appears to be diminishing in daily life,only a limited number of drugs have received approval or emergency use authorization for its treatment.Given the high mutation rate of viral genomes,host-directed agents(HDAs)have emerged as a preferred choice due to their broad applicability and lasting effectiveness.In contrast to direct-acting antivirals(DAAs),HDAs offer several advantages,including broad-spectrum antiviral activities,potential efficacy against future emerging viruses,and a lower likelihood of inducing drug resistance.In our review article,we have synthesized known host-directed antiviral targets that span diverse cellular pathways and mechanisms,shedding light on the intricate interplay between host cells and viruses.Additionally,we have provided a brief overview of the development of HDAs based on these targets.We aim for this comprehensive analysis to offer valuable perspectives and insights that can guide future antiviral research and drug development efforts.
出处 《Acta Pharmaceutica Sinica B》 2025年第4期1723-1751,共29页 药学学报(英文版)
基金 supported by the National Program for Support of Top-notch Young Professionals(Grant No.0106514050 to Yonghui Zhang,China) the National Natural Science Foundation of China(Grant Nos.82273811 and U22A20380 to Yonghui Zhang) the National Key Research and Development Program of China(Grant No.2021YFA0910500 to Yonghui Zhang) TongjiRongcheng Center for Biomedicine,Huazhong University of Science and Technology。
  • 相关文献

参考文献4

二级参考文献91

  • 1Gern JE. The ABCs of rhinoviruses, wheezing, and asthma. J Viro12010; 84:7418-7426.
  • 2Mallia P, Contoli M, Caramori G, Pandit A, Johnston Sir, Papi A. Exacerbations of asthma and chronic obstructive puhno- nary disease (COPD): fbcus on virus induced exacerbations. Curr Pharm Des 2007; 13:73-97.
  • 3Tebruegge M, Curtis N. Enterovirus infections in neonates. Semin Fetal Neonatal Med 2009; 14:222-227.
  • 4Whitton JL, Cornell CT, Feuer R. Host and virus determinants of picomavirus pathogenesis and tropism. Nat Rev Microbiol 2005; 3:765-776.
  • 5Bible JM, Pantelidis P, Chan PK, Tong CY. Genetic evolutionof enterovirus 71: epidemiological and pathological implica- tions. Rev Med Virol 2007; 17:371-379.
  • 6Bedard KM, Semler BL. Regulation of picornavirus gene ex- pression. Microbes lnfect 2004; 6:702-713.
  • 7Heinz BA, Vance LM. The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus:! Drol 1995; 69:4189-4197.
  • 8Heinz BA and Vance LM. Sequence determinants of 3A- mediated resistance to enviroxime in rhinoviruses and entero- viruses. J Virol 1996; 70:4854-4857.
  • 9Wikel JH, Paget C J, DeLong DC, et al. Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-I-[(1- methylethyl)sulfonyl]- 1H-benzimidazol-2-amine. Inhibitors of rhinovirus multiplication. J Med Chem 1980; 23:368-372.
  • 10Brown-Augsburger P, Vance LM, Malcolm SK, Hsiung H: Smith DP, Heinz BA. Evidence that enviroxime targets mul- tiple components of the rhinovirus 14 replication complex. Arch Virol 1999; 144:1569-1585.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部